Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05708703 · ClinicalTrials.gov registry record
Assessing the Time Demands of Cancer
A clinical trial of Ovarian Cancer and Metastatic Breast Cancer, sponsored by Masonic Cancer Center, University of Minnesota.
- Active
- Registry status
- 78
- Enrollment target
- 2
- Study locations
NCT05708703 is a study of Ovarian Cancer and Metastatic Breast Cancer that is active but no longer recruiting, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 78 participants, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT05708703, a study of Ovarian Cancer and Metastatic Breast Cancer, is active but no longer recruiting, sponsored by Masonic Cancer Center, University of Minnesota.
- ACTIVE NOT RECRUITING
- Registry status
- 78 participants
- Enrollment target
- 2
- Study locations
Study Summary
A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion services active; confirm and correct (if needed) smartphone-detected activities and trips; use the app interface to provide additional information on activities and trips related to cancer treatment tasks; complete daily surveys regarding well-being; and at the end of the 28 day period, complete an online survey.
Conditions Studied
Study Locations (2)
Alabama
- University of Alabama - Birmingham
Minnesota
- Masonic Cancer Center - University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2023-11-13 |
| Est. Completion | 2030-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05708703
The ClinicalTrials.gov registry entry for NCT05708703 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 729-participant average among 322 other Ovarian Cancer trials with a reported enrollment target (89% lower). The listed sponsor is Masonic Cancer Center, University of Minnesota, which has 249 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Ovarian Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05708703 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Minnesota.
Frequently Asked Questions
What is clinical trial NCT05708703 about?
NCT05708703 is a clinical study titled "Assessing the Time Demands of Cancer". A total of 80 individuals receiving treatment for metastatic breast or advanced stage ovarian cancer will be asked to complete a baseline survey and install the mobile app on their smartphone; carry the smartphone for 28 consecutive days while outside the home; keep smartphone location and motion se...
What is the current status of trial NCT05708703?
This trial is currently active not recruiting. The enrollment target is 78 participants. The study started on 2023-11-13. Estimated completion is 2030-12-31.
What conditions does trial NCT05708703 study?
This clinical trial studies the following conditions: Ovarian Cancer, Metastatic Breast Cancer.
Who is sponsoring clinical trial NCT05708703?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05708703 being conducted?
This trial has 2 study locations across Alabama, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ovarian Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
RECRUITING
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study to Assess Adverse Events, Change in Disease Activity and How Intravenous (IV) ABBV901 Moves Through the Body Alone or in Combination With Bevacizumab in Adult Participants With Ovarian Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.